research use only

Sodium Hyaluronate

Cat.No.S5650

Sodium hyaluronate is the sodium salt of hyaluronic acid, a glycosaminoglycan found in various connective tissue of humans.
Sodium Hyaluronate Chemical Structure

Chemical Structure

Jump to

Quality Control

Batch: S565001 Water]4 mg/mL]true]]]false]]]false Purity: 98%
98

Solubility

In vitro
Batch:

Water : 4 mg/mL (Warmed with 50℃ water bath; Ultrasonicated)

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight Formula Storage (From the date of receipt) 3 years -20°C powder
CAS No. 9067-32-7 -- Storage of Stock Solutions

Synonyms N/A Smiles [Na+].CC(=O)NC1C(C(O)C(CO)OC1OC2C(O)C(O)C(O[*])OC2C([O-])=O)[*]

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04569656 Completed
Parkinson Disease
IRCCS San Raffaele Roma
February 2 2016 Phase 2
NCT00349024 Unknown status
Brain and Central Nervous System Tumors|Chordoma|Kidney Cancer|Leukemia|Lymphoma|Mucositis|Neuroblastoma|Pain|Sarcoma|Unspecified Childhood Solid Tumor Protocol Specific
Children''s Cancer and Leukaemia Group|National Cancer Institute (NCI)
July 2005 Not Applicable
NCT00377624 Completed
Osteoarthritis of Shoulder
Sanofi
January 2002 Phase 3

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.